Say‐Beng Tan

1.6k total citations · 1 hit paper
16 papers, 1.2k citations indexed

About

Say‐Beng Tan is a scholar working on Statistics and Probability, Epidemiology and Ophthalmology. According to data from OpenAlex, Say‐Beng Tan has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Statistics and Probability, 5 papers in Epidemiology and 4 papers in Ophthalmology. Recurrent topics in Say‐Beng Tan's work include Statistical Methods in Clinical Trials (7 papers), Ophthalmology and Visual Impairment Studies (4 papers) and Optimal Experimental Design Methods (4 papers). Say‐Beng Tan is often cited by papers focused on Statistical Methods in Clinical Trials (7 papers), Ophthalmology and Visual Impairment Studies (4 papers) and Optimal Experimental Design Methods (4 papers). Say‐Beng Tan collaborates with scholars based in Singapore, United Kingdom and Australia. Say‐Beng Tan's co-authors include Seang‐Mei Saw, Tien Yin Wong, David Machin, Pierce K. H. Chow, Hwee-Bee Wong, London Lucien Ooi, Miao Shan Lim, John Carson Allen, Alexander Chung and Peng Chung Cheow and has published in prestigious journals such as PLoS ONE, Annals of Surgery and Ophthalmology.

In The Last Decade

Say‐Beng Tan

16 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria

2011 423 citations Pierce K. H. Chow, John Carson Allen et al. Annals of Surgery profile →

Peers

Countries citing papers authored by Say‐Beng Tan

Since Specialization

Citations

This map shows the geographic impact of Say‐Beng Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Say‐Beng Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Say‐Beng Tan more than expected).

Fields of papers citing papers by Say‐Beng Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Say‐Beng Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Say‐Beng Tan. The network helps show where Say‐Beng Tan may publish in the future.

Co-authorship network of co-authors of Say‐Beng Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Say‐Beng Tan. A scholar is included among the top collaborators of Say‐Beng Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Say‐Beng Tan. Say‐Beng Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma 2014 ·PLoS ONE ·Pierce K. H. Chow, Donald Poon, Khin Maung Win, Harjit Singh, Ho‐Seong Han, Anthony Goh, Su Pin Choo, (unknown), Richard Hoau Gong Lo, Kiang‐Hiong Tay, (unknown), Mihir Gandhi, Say‐Beng Tan, Khee‐Chee Soo, (unknown)	55
2	Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria breakdown → 2011 ·Annals of Surgery ·(unknown), Pierce K. H. Chow, John Carson Allen, (unknown), Miao Shan Lim, Peng Chung Cheow, Alexander Chung, London Lucien Ooi, Say‐Beng Tan	423
3	The effect of body mass on health-related quality of life among Singaporean adolescents: results from the SCORM study 2010 ·Quality of Life Research ·Truls Østbye, Rahul Malhotra, Hwee-Bee Wong, Say‐Beng Tan, Seang‐Mei Saw	27
4	Phase II clinical trials in oncology: are we hitting the target? 2010 ·Expert Review of Anticancer Therapy ·Mei‐Kim Ang, Say‐Beng Tan, Wan‐Teck Lim	4
5	Ocular Component Growth Curves among Singaporean Children with Different Refractive Error Status 2010 ·Investigative Ophthalmology & Visual Science ·Hwee-Bee Wong, David Machin, Say‐Beng Tan, Tien Yin Wong, Seang‐Mei Saw	125
6	The Singapore 5-Fluorouracil Trabeculectomy Study 2009 ·Ophthalmology ·Tina Wong, Peng T. Khaw, Tin Aung, Paul J. Foster, Hla Myint Htoon, Francis T.S. Oen, Gus Gazzard, Rahat Husain, Joe G. Devereux, Darwin Minassian, Say‐Beng Tan, Paul Chew, Steve K.L. Seah	73
7	Visual Impairment and Its Impact on Health-related Quality of Life in Adolescents 2008 ·American Journal of Ophthalmology ·Hwee-Bee Wong, David Machin, Say‐Beng Tan, Tien Yin Wong, Seang‐Mei Saw	77
8	Can external and subjective information ever be used to reduce the size of randomised controlled trials? 2007 ·Contemporary Clinical Trials ·Say‐Beng Tan, Joseph Wee, Hwee-Bee Wong, David Machin	5
9	Bayesian two-stage designs for phase II clinical trials by S. B. Tan and D. Machin,Statistics in Medicine 2002;21:1991–2012 2006 ·Statistics in Medicine ·Say‐Beng Tan, David Machin	5
10	A Cohort Study of Incident Myopia in Singaporean Children 2006 ·Investigative Ophthalmology & Visual Science ·Seang‐Mei Saw, Anoop Shankar, Say‐Beng Tan, Hugh R. Taylor, Donald Tan, Richard A. Stone, Tien Yin Wong	165
11	A Bayesian dose finding design for dual endpoint phase I trials 2005 ·Statistics in Medicine ·(unknown), Say‐Beng Tan, Yiyu Cai, David Machin	17
12	Where's the utility in Bayesian data-monitoring of clinical trials? 2005 ·Clinical Trials ·Deborah Ashby, Say‐Beng Tan	9
13	Bayesian designs with frequentist and Bayesian error rate considerations 2005 ·Statistical Methods in Medical Research ·You‐Gan Wang, Denis H. Y. Leung, (unknown), Say‐Beng Tan	21
14	IQ and the Association with Myopia in Children 2004 ·Investigative Ophthalmology & Visual Science ·Seang‐Mei Saw, Say‐Beng Tan, Daniel Fung, Kee‐Seng Chia, David Koh, Donald Tan, Richard A. Stone	122
15	Elicitation of prior distributions for a phase III randomized controlled trial of adjuvant therapy with surgery for hepatocellular carcinoma 2003 ·Controlled Clinical Trials ·Say‐Beng Tan, Y F A Chung, Bee‐Choo Tai, Yin‐Bun Cheung, David Machin	25
16	Quick-FLIC 2003 ·Acta Oncologica ·Yin‐Bun Cheung, (unknown), (unknown), (unknown), (unknown), Richard J. Epstein, (unknown), Say‐Beng Tan	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kadir Bahar Breakdown of academic impact, for papers by Kerstin A. Kessel Breakdown of academic impact, for papers by Joann Fontanarosa Breakdown of academic impact, for papers by Ping Hou Breakdown of academic impact, for papers by Jin Joo Kim Breakdown of academic impact, for papers by Robert Lehr Breakdown of academic impact, for papers by Natalie Wong Breakdown of academic impact, for papers by Marco Fornili